Nonhuman primate models to evaluate vaccine safety and immunogenicity

Area of Science:

• Primate immunology
• Vaccine development
• Comparative genomics

Background:

• Preclinical vaccine studies require careful species selection for safety and immunogenicity evaluation.
• Phylogenetic relatedness to humans is a key factor in choosing nonhuman primate models.
• Great apes, though closely related, present ethical and logistical challenges for research.

Purpose of the Study:

• To discuss the advantages and disadvantages of different nonhuman primate species for DNA vaccine preclinical studies.
• To highlight the importance of considering phylogenetic distance, cost, and species-specific factors.
• To provide insights into selecting appropriate models for vaccine safety and immunogenicity testing.

Main Methods:

• Comparative analysis of nonhuman primate species based on phylogenetic divergence from humans.
• Review of existing literature on the use of great apes, Old World monkeys, and New World monkeys in biomedical research.
• Consideration of factors including immunology, reproductive physiology, endogenous agents, and cost.

Main Results:

• Great apes are phylogenetically closest but limited by conservation status and cost.
• Old World monkeys (e.g., macaques) are widely used, offering a balance of relatedness and practicality.
• New World monkeys, though more divergent, are also utilized for specific disease models.

Conclusions:

• The choice of nonhuman primate model for DNA vaccine evaluation involves balancing phylogenetic proximity with practical constraints.
• Old World monkeys represent a viable option for many preclinical vaccine studies.
• Further research may refine the selection criteria for optimal nonhuman primate models in vaccinology.